Industry no doubt welcomes the Commission’s long-overdue review of the European Cosmetics Regulation as it pertains to chemicals with endocrine-disrupting properties. The report concludes that the existing regulatory framework is adequate to evaluate and manage suspected endocrine disruptors, while putting stakeholders on notice that a number of prioritized ingredients will be up for review in 2019.
The European Commission has finally completed its review of the Cosmetics Regulation as it relates to substances with endocrine-disrupting properties, and for industry at least, the wait was worth it.
The EU’s Cosmetics Regulation, which in July 2013 replaced the Cosmetics Directive of 1976, includes a provision requiring the regulation's...
UK consumer advocacy organization finds more than two-thirds of 34 skin care and makeup products it purchased from third party sellers on major ecommerce sites are likely fake.
What's going on with the EU Green Claims Directive? HBW Insight speaks to the European Commission, Parliament and Council to find out why trilogue negotiations seem to have stalled.
While FDA fully supports the recent roadmap to reduce and eliminate animal testing, animal tests are still necessary for assessing systemic effects, says Jacqueline Corrigan-Curay, acting director for CDER, during a House Energy and Commerce Health Subcommittee hearing.
The European Commission’s Simplification Omnibus published July 8 is ‘step in right direction’ for streamlining processes and providing more legal certainty and predictability for regulations addressing cosmetics, says Cosmetics Europe.
The Personal Care Products Council identifies sunscreen regulations among federal laws that place US industry at a competitive disadvantage, in comments to the Federal Trade Commission and the US Department of Justice Antitrust Division.
A national wholesalers’ trade group is suing Oregon, claiming its EPR law, which requires producers to register, report packaging data and pay fees, is unconstitutional and overly burdensome.
OMUFA reauthorization bill including amendment with sunscreen regulation provisions passed by Senate committee, which also approved other provisions not included in House OMUFA bill.
